Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.
Samson SL. Samson SL. Drugs. 2016 Sep;76(13):1235-1243. doi: 10.1007/s40265-016-0615-y. Drugs. 2016. PMID: 27473537 Review.
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.
Sathyanarayana P, Jogi M, Muthupillai R, Krishnamurthy R, Samson SL, Bajaj M. Sathyanarayana P, et al. Among authors: samson sl. Obesity (Silver Spring). 2011 Dec;19(12):2310-5. doi: 10.1038/oby.2011.152. Epub 2011 Jun 9. Obesity (Silver Spring). 2011. PMID: 21660077 Clinical Trial.
Potential of incretin-based therapies for non-alcoholic fatty liver disease.
Samson SL, Bajaj M. Samson SL, et al. J Diabetes Complications. 2013 Jul-Aug;27(4):401-6. doi: 10.1016/j.jdiacomp.2012.12.005. Epub 2013 Jan 24. J Diabetes Complications. 2013. PMID: 23352496 Review.
GLP-1R agonist therapy for diabetes: benefits and potential risks.
Samson SL, Garber A. Samson SL, et al. Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):87-97. doi: 10.1097/MED.0b013e32835edb32. Curr Opin Endocrinol Diabetes Obes. 2013. PMID: 23403741 Review.
Metabolic syndrome.
Samson SL, Garber AJ. Samson SL, et al. Endocrinol Metab Clin North Am. 2014 Mar;43(1):1-23. doi: 10.1016/j.ecl.2013.09.009. Endocrinol Metab Clin North Am. 2014. PMID: 24582089 Review.
Cardiovascular effects of incretin therapy in diabetes care.
Kim J, Samson SL. Kim J, et al. Among authors: samson sl. Metab Syndr Relat Disord. 2014 Aug;12(6):303-10. doi: 10.1089/met.2014.0035. Epub 2014 May 19. Metab Syndr Relat Disord. 2014. PMID: 24842063 Free PMC article. Review.
Long-term medical treatment of cushing's disease with pasireotide: a review of current evidence and clinical experience.
Samson SL. Samson SL. Exp Clin Endocrinol Diabetes. 2014 Sep;122(8):445-50. doi: 10.1055/s-0034-1376988. Epub 2014 Jul 8. Exp Clin Endocrinol Diabetes. 2014. PMID: 25003365 Review.
Pasireotide in Acromegaly: An Overview of Current Mechanistic and Clinical Data.
Samson SL. Samson SL. Neuroendocrinology. 2015;102(1-2):8-17. doi: 10.1159/000381460. Epub 2015 Mar 16. Neuroendocrinology. 2015. PMID: 25792118
Prevention of type 2 Diabetes Mellitus: Potential of pharmacological agents.
Samson SL, Garber AJ. Samson SL, et al. Best Pract Res Clin Endocrinol Metab. 2016 Jun;30(3):357-71. doi: 10.1016/j.beem.2016.06.005. Epub 2016 Jun 15. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 27432071 Review.
A Plethora of GLP-1 Agonists: Decisions About What to Use and When.
Samson SL, Garber AJ. Samson SL, et al. Curr Diab Rep. 2016 Dec;16(12):120. doi: 10.1007/s11892-016-0823-6. Curr Diab Rep. 2016. PMID: 27766579 Review.
81 results
Jump to page